Mecuris is a Munich based medical technology start-up, which specializes in the digitization of prostheses and orthotics. They successfully conclude a Series A financing round worth 3.6 million euros. In addition to the existing seed investors Bayern Kapital and High-Tech Gründerfonds (HTGF), Vesalius Biocapital, Mulcan International Investments and one of the top five hospital chains in Germany are now also on board.
The money should flow into the development of the European market and the strengthening of sales. In addition, the start-up intends to continue to develop new digital solutions to complement its own portfolio and close market gaps.
Mercuris was founded by Manuel Opitz and Wolf-Peter Werner. They develops individual, custom-made orthoses and prostheses together with orthopedic technicians and patients. These are produced by means of 3D printing and delivered within a few days.